Global Trastuzumab Tenders and GPN from across the Globe

Inj Trastuzumab Deruxtecan 100 mg, Qty: 9 No, (BOQ Item #61)

Drug Supply - the Active Substance Trastuzumab for Subcutaneous Administration - Atc L01fd01

Ib2025-018C Supply and Delivery of Trastuzumab 150 Mg Lyophilized Powder - Framework Agreement

Treatment Tender for Trastuzumab 440 Mg Powder and Solvent for Concentrate for Solution for Infusion, 1 Vin, 200 Vil Viin with the E-Bidding (Project Number) (68039202469)

Open-House Drug Discount Contracts in Accordance with Section 130A (8C) Sgb V Trastuzumab, Atc L01fd01-Contract Regions of Lower Saxony, Bremen and Saxony-Anhalt

Antineoplastic and Immunomodulatory Agent Description: Part 1 Trastuzumab Deruxtekan Plc Ifc 1X100 Mg (Medad.Inj.Skl. Jantar.)

Acquisition of Medicine to Meet a Court Order

Pertuzumab 600Mg + Trastuzumab 600Mg Inj in Vial

Trastuzumab Deruxtecan 100Mg Inj

Notice Inviting Tender for Inj Trastuzumab Deruxtecan (LANGUAGE - ENGLISH)